Clinical Trial Update: Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the feasibility of administering an acellular pertussis vaccine soon after birth, followed by a 3-dose primary vaccination with DTP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• DTPa-HBV-IPV/Hib vaccine (DTPa-HBV-IPV/Hib vaccine)
• acellular pertussis vaccine (Pa) (acellular pertussis vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED